Biopharmaceutical Research Company
PrivateLast Round
Series A
Oct 4, 2022
Total Funding Raised
$20M
Company Overview
Biopharmaceutical Research Company is a biopharmaceutical and cannabis testing company specializing in plant-based therapeutics and providing comprehensive analysis for potency, contaminant testing, and stability data to support research on treatments for post-traumatic stress disorder, chronic pain, and other conditions affecting patients and veterans.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Pharma Supply Chain, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biopharmaceutical Research Company Comps
Public and private peers based on sector, stage, and business model.
Biopharmaceutical Research Company Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 4, 2022 |
Biopharmaceutical Research Company Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Intrinsic Capital Partners | Series A |
| Delta Emerald Ventures | Series A |
| AFI Capital Partners | Series A |
| Argonautic Ventures | Series A |
Biopharmaceutical Research Company Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Biopharmaceutical Research Company's valuation, stock price, and market status.